Astrid Zimmermann

2.4k total citations
76 papers, 1.7k citations indexed

About

Astrid Zimmermann is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Astrid Zimmermann has authored 76 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 27 papers in Oncology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Astrid Zimmermann's work include DNA Repair Mechanisms (20 papers), Cancer therapeutics and mechanisms (14 papers) and Cancer-related Molecular Pathways (11 papers). Astrid Zimmermann is often cited by papers focused on DNA Repair Mechanisms (20 papers), Cancer therapeutics and mechanisms (14 papers) and Cancer-related Molecular Pathways (11 papers). Astrid Zimmermann collaborates with scholars based in Germany, United States and Switzerland. Astrid Zimmermann's co-authors include Arne Sutter, Gennadij Raivich, Klaus Hahlbrock, Rićhard P. Hill, Frank T. Zenke, Andree Blaukat, Jean A. Laissue, Eric M. Shooter, Heike Dahmen and Mouming Zhao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Astrid Zimmermann

74 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Astrid Zimmermann Germany 20 891 465 397 210 208 76 1.7k
Jee‐Yin Ahn South Korea 26 1.2k 1.4× 237 0.5× 297 0.7× 146 0.7× 84 0.4× 77 2.0k
M Noble United Kingdom 16 656 0.7× 264 0.6× 158 0.4× 143 0.7× 387 1.9× 30 1.6k
Haris G. Vikis United States 23 1.5k 1.7× 523 1.1× 440 1.1× 340 1.6× 109 0.5× 33 2.3k
Maria L. Macheda Australia 12 1.2k 1.3× 215 0.5× 288 0.7× 575 2.7× 106 0.5× 14 1.8k
Hye Shin Lee South Korea 19 820 0.9× 154 0.3× 248 0.6× 114 0.5× 60 0.3× 28 1.2k
Hiroko Iwanari Japan 18 949 1.1× 251 0.5× 221 0.6× 131 0.6× 25 0.1× 31 1.7k
Jiefei Tong Canada 28 1.8k 2.0× 449 1.0× 352 0.9× 173 0.8× 28 0.1× 43 2.3k
Dara Ditsworth United States 19 2.0k 2.2× 245 0.5× 484 1.2× 781 3.7× 109 0.5× 21 3.2k
Amee J. George Australia 16 1.2k 1.4× 153 0.3× 308 0.8× 195 0.9× 34 0.2× 22 1.9k
Dongmei Zuo Canada 27 1.6k 1.8× 110 0.2× 385 1.0× 329 1.6× 32 0.2× 54 2.2k

Countries citing papers authored by Astrid Zimmermann

Since Specialization
Citations

This map shows the geographic impact of Astrid Zimmermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Zimmermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Zimmermann more than expected).

Fields of papers citing papers by Astrid Zimmermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Zimmermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Zimmermann. The network helps show where Astrid Zimmermann may publish in the future.

Co-authorship network of co-authors of Astrid Zimmermann

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Zimmermann. A scholar is included among the top collaborators of Astrid Zimmermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Zimmermann. Astrid Zimmermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kato, Megumi, Satoshi Endo, Randal K. Wada, et al.. (2025). PARP inhibition-associated heterochromatin confers increased DNA replication stress and vulnerability to ATR inhibition in SMARCA4-deficient cells. Cell Death Discovery. 11(1). 31–31. 1 indexed citations
2.
Dupuy, Nathalie, Frances A. Brightman, Astrid Zimmermann, et al.. (2025). Semi-mechanistic efficacy model for PARP + ATR inhibitors—application to rucaparib and talazoparib in combination with gartisertib in breast cancer PDXs. British Journal of Cancer. 132(5). 481–491. 2 indexed citations
3.
Jo, Ukhyun, Yasuhiro Arakawa, Astrid Zimmermann, et al.. (2024). The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs. Molecular Cancer Therapeutics. 23(7). 911–923. 10 indexed citations
4.
Budzinska, Magdalena A., Olga Bogatyrova, F. Neumann, et al.. (2023). DNA-Dependent Protein Kinase Inhibitor Peposertib Potentiates the Cytotoxicity of Topoisomerase II Inhibitors in Synovial Sarcoma Models. Cancers. 16(1). 189–189. 2 indexed citations
5.
Jo, Ukhyun, Yasuhiro Arakawa, Astrid Zimmermann, et al.. (2023). Abstract LB301: Molecular pharmacology and broad synergy of the novel ATR inhibitor M1774 with DNA damaging anticancer agents. Cancer Research. 83(8_Supplement). LB301–LB301. 1 indexed citations
6.
Turchick, Audrey, Astrid Zimmermann, Li-Ya Chiu, et al.. (2023). Selective Inhibition of ATM-dependent Double-strand Break Repair and Checkpoint Control Synergistically Enhances the Efficacy of ATR Inhibitors. Molecular Cancer Therapeutics. 22(7). 859–872. 16 indexed citations
7.
Sirrenberg, Christian, et al.. (2023). Abstract 6215: Peposertib, a DNA-PK inhibitor, enhances the antitumor efficacy of anthracyclines in triple-negative breast cancer models in vitro and in vivo. Cancer Research. 83(7_Supplement). 6215–6215. 1 indexed citations
8.
Zimmermann, Astrid, Frank T. Zenke, Li-Ya Chiu, et al.. (2022). A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies. Molecular Cancer Therapeutics. 21(6). 859–870. 32 indexed citations
9.
Jo, Ukhyun, Ilya S. Senatorov, Astrid Zimmermann, et al.. (2021). Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents. Molecular Cancer Therapeutics. 20(8). 1431–1441. 75 indexed citations
10.
Bogatyrova, Olga, Johanna Sofia Margareta Mattsson, Edith Ross, et al.. (2021). FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response. European Journal of Cancer. 151. 136–149. 32 indexed citations
11.
Zenke, Frank T., Astrid Zimmermann, Christian Sirrenberg, et al.. (2020). Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models. Molecular Cancer Therapeutics. 19(5). 1091–1101. 118 indexed citations
12.
Zimmermann, Astrid, et al.. (2020). DNA-PK Inhibitor, M3814, as a New Combination Partner of Mylotarg in the Treatment of Acute Myeloid Leukemia. Frontiers in Oncology. 10. 127–127. 24 indexed citations
13.
Almquist, J.O., et al.. (2019). Modeling long-term tumor growth and kill after combinations of radiation and radiosensitizing agents. Cancer Chemotherapy and Pharmacology. 83(6). 1159–1173. 8 indexed citations
14.
Klein, Carmen, Ivana Đokić, Andrea Mairani, et al.. (2017). Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation. Radiation Oncology. 12(1). 208–208. 84 indexed citations
15.
Zimmermann, Astrid, et al.. (2016). Extending the Tumor Static Concentration curve to average doses - a combination therapy example using radiation therapy. Chalmers Publication Library (Chalmers University of Technology). 1 indexed citations
16.
Hoppe, Edmund, Nicola J. Hewitt, Hans‐Peter Buchstaller, et al.. (2014). A Novel Strategy for ADME Screening of Prodrugs: Combined Use of Serum and Hepatocytes to Integrate Bioactivation and Clearance, and Predict Exposure to Both Active and Prodrug to the Systemic Circulation. Journal of Pharmaceutical Sciences. 103(5). 1504–1514. 8 indexed citations
17.
Zimmermann, Astrid, et al.. (2000). Liver nodules resembling focal nodular hyperplasia after hepatic venous thrombosis. Journal of Hepatology. 33(4). 673–676. 8 indexed citations
18.
19.
Zimmermann, Astrid. (1998). Growth pattern and NGF-dependent survival of dorsal root ganglia neurons of distinct glyco-phenotype. Journal of Neurobiology. 34(3). 193–207. 1 indexed citations
20.
Zimmermann, Astrid, et al.. (1991). Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells. British Journal of Cancer. 64(4). 663–670. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jee‐Yin Ahn Breakdown of academic impact, for papers by M Noble Breakdown of academic impact, for papers by Haris G. Vikis Breakdown of academic impact, for papers by Maria L. Macheda Breakdown of academic impact, for papers by Hye Shin Lee Breakdown of academic impact, for papers by Hiroko Iwanari Breakdown of academic impact, for papers by Jiefei Tong Breakdown of academic impact, for papers by Dara Ditsworth Breakdown of academic impact, for papers by Amee J. George Breakdown of academic impact, for papers by Dongmei Zuo
Rankless by CCL
2026